• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The post-antimicrobial suppressive effect of quinolone agents.

作者信息

Neu H C, Kumada T, Chin N X, Mandell W

出版信息

Drugs Exp Clin Res. 1987;13(2):63-7.

PMID:3107958
Abstract

A post-antimicrobial effect (PAE) was seen with all of the new 4-quinolones studied: ciprofloxacin, ofloxacin, Cl-934, Ro 23-6240, A-56619 and S-25930. The post-antimicrobial suppression of growth was for 4-8 h in the case of Escherichia coli, Klebsiella pneumoniae, Serratia marcescens and Pseudomonas aeruginosa. PEA was demonstrated both in Mueller-Hinton broth at pH 7.4 and in urine at pH 5.5 with a Mg2+ concentration of 9.5 mM. Resistant organisms, with MICs greater than 4 micrograms/ml, showed a PAE after a 2-h exposure to 200 micrograms/ml of 4-quinolones. This demonstrates that PAE is seen for 4-quinolones even under conditions in which they are less active.

摘要

相似文献

1
The post-antimicrobial suppressive effect of quinolone agents.
Drugs Exp Clin Res. 1987;13(2):63-7.
2
Post-antibiotic suppressive effect of ciprofloxacin against gram-positive and gram-negative bacteria.环丙沙星对革兰氏阳性菌和革兰氏阴性菌的抗生素后效应
Am J Med. 1987 Apr 27;82(4A):58-62.
3
[In vitro antibacterial activity of ciprofloxacin against uropathogenic organisms].环丙沙星对尿路致病微生物的体外抗菌活性
Boll Soc Ital Biol Sper. 1984 Oct 30;60(10):1927-33.
4
Phenotypic resistance of Staphylococcus aureus, selected Enterobacteriaceae, and Pseudomonas aeruginosa after single and multiple in vitro exposures to ciprofloxacin, levofloxacin, and trovafloxacin.金黄色葡萄球菌、特定肠杆菌科细菌及铜绿假单胞菌在体外单次及多次暴露于环丙沙星、左氧氟沙星和曲伐沙星后的表型耐药性。
Antimicrob Agents Chemother. 2001 Mar;45(3):883-92. doi: 10.1128/AAC.45.3.883-892.2001.
5
Influence of pH and human urine on the antibacterial activity of ciprofloxacin, norfloxacin and ofloxacin.pH值和人尿对环丙沙星、诺氟沙星和氧氟沙星抗菌活性的影响。
Drugs Exp Clin Res. 1985;11(5):335-8.
6
[Enoxacin and ciprofloxacin: in vitro effect on Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus].[依诺沙星和环丙沙星:对肠杆菌科细菌、铜绿假单胞菌和金黄色葡萄球菌的体外作用]
Med Clin (Barc). 1986 Jan 11;86(1):1-3.
7
Inhibitory and bactericidal activities of amifloxacin, a new quinolone carboxylic acid, compared with those of seven other antimicrobial agents.
Clin Ther. 1984;7(1):73-80.
8
The comparative activity of twelve 4-quinolone antimicrobials against gram-positive and gram-negative anaerobes.
Drugs Exp Clin Res. 1985;11(7):431-4.
9
Antimicrobial activity of fluoroquinolones and other antibiotics on 1,116 clinical gram-positive and gram-negative isolates.氟喹诺酮类及其他抗生素对1116株临床革兰氏阳性和革兰氏阴性分离菌的抗菌活性。
Drugs Exp Clin Res. 1998;24(3):139-51.
10
Experience with ciprofloxacin in vitro and in vivo.
Arzneimittelforschung. 1984;34(12):1775-8.

引用本文的文献

1
Inoculum-Based Dosing: A Novel Concept for Combining Time with Concentration-Dependent Antibiotics to Optimize Clinical and Microbiological Outcomes in Severe Gram Negative Sepsis.基于接种量的给药:一种将时间与浓度依赖性抗生素相结合以优化重症革兰氏阴性菌败血症临床和微生物学结果的新概念。
Antibiotics (Basel). 2023 Oct 31;12(11):1581. doi: 10.3390/antibiotics12111581.
2
Antibiotic pharmacokinetic and pharmacodynamic considerations in critical illness.危重症中抗生素的药代动力学和药效学考量
Intensive Care Med. 2004 Dec;30(12):2145-56. doi: 10.1007/s00134-004-2428-9. Epub 2004 Nov 5.
3
Use of fluoroquinolone antimicrobial agents by cardiovascular and cardiopulmonary surgeons.
心血管和心肺外科医生对氟喹诺酮类抗菌药物的使用。
Tex Heart Inst J. 1990;17(1):12-21.
4
Evaluation of the efficacy of ciprofloxacin against Streptococcus pneumoniae by using a mouse protection model.通过使用小鼠保护模型评估环丙沙星对肺炎链球菌的疗效。
Antimicrob Agents Chemother. 1993 Feb;37(2):234-9. doi: 10.1128/AAC.37.2.234.
5
Fleroxacin. A review of its pharmacology and therapeutic efficacy in various infections.氟罗沙星。对其在各种感染中的药理学及治疗效果的综述。
Drugs. 1995 May;49(5):794-850. doi: 10.2165/00003495-199549050-00010.
6
Levofloxacin. A review of its antibacterial activity, pharmacokinetics and therapeutic efficacy.左氧氟沙星。对其抗菌活性、药代动力学及治疗效果的综述。
Drugs. 1994 Apr;47(4):677-700. doi: 10.2165/00003495-199447040-00008.
7
Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.环丙沙星:抗菌活性、药代动力学特性及治疗用途综述
Drugs. 1988 Apr;35(4):373-447. doi: 10.2165/00003495-198835040-00003.
8
Fluoroquinolone antimicrobial agents.氟喹诺酮类抗菌剂。
Clin Microbiol Rev. 1989 Oct;2(4):378-424. doi: 10.1128/CMR.2.4.378.
9
Impact of the dosage schedule on the efficacy of ceftazidime, gentamicin and ciprofloxacin in Klebsiella pneumoniae pneumonia and septicemia in leukopenic rats.
Eur J Clin Microbiol Infect Dis. 1989 Oct;8(10):878-87. doi: 10.1007/BF01963774.
10
Comparative in vitro activity of a new quinolone, fleroxacin, against respiratory pathogens from patients with cystic fibrosis.新型喹诺酮类药物氟罗沙星对囊性纤维化患者呼吸道病原体的体外活性比较
Antimicrob Agents Chemother. 1990 Oct;34(10):1880-4. doi: 10.1128/AAC.34.10.1880.